| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2015 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HYPERION THERAPEUTICS INC. | 1 | Q2 2013 | 16.8% |
| FURIEX PHARMACEUTICAL, INC. | 1 | Q2 2013 | 13.3% |
| STEMLINE THERAPEUTICS INC. | 1 | Q2 2013 | 11.2% |
| BIODEL INC. | 1 | Q2 2013 | 6.1% |
| AMBIT BIOSCIENCES CORP | 1 | Q2 2013 | 5.5% |
| GERON CORPORATION | 1 | Q2 2013 | 4.4% |
| PAIN THERAPEUTICS INC. | 1 | Q2 2013 | 4.1% |
| SUNSHINE HEART INC. | 1 | Q2 2013 | 4.0% |
| DURATA THERAPEUTICS INC. | 1 | Q2 2013 | 3.6% |
| NORDION INC. | 1 | Q2 2013 | 3.1% |
View JAY JEFFREY R's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| FORBES MEDI TECH INC | January 16, 2004 | 2,891,818 | 9.8% |
View JAY JEFFREY R's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-02-14 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
| 13F-NT | 2023-05-15 |
| 13F-NT | 2023-02-14 |
| 13F-NT | 2022-11-14 |
| 13F-NT | 2022-08-15 |
| 13F-NT | 2022-05-16 |
| 13F-NT | 2022-02-14 |
| 13F-NT | 2021-11-15 |
View JAY JEFFREY R's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.